Pfizer said last week it would pay $47.50 per share for Metsera, and an extra $22.50 per share if its drugs hit certain ...

Ozempic has been approved in India for type 2 diabetes. The blockbuster drug by Danish drugmaker Novo Nordisk has taken the ...

Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 5.9% in the afternoon session after the company reached an ...

President Donald Trump and Pfizer's CEO today announced "TrumpRX" and lower drug prices. But what does Pfizer sell? Here's ...

Novo Nordisk (NVO) has cemented itself as the leader in the booming weight-loss drug market with blockbuster treatments like ...

In a Phase 2 trial, a drug at the center of the $4.9 billion deal matched the type of weight loss trajectory seen in testing ...

Ozempic, a popular medication for type 2 diabetes and weight management, is set to debut in India soon. Known for helping ...

ONLINE crooks are already trying to trick desperate Brits into buying the next big fat jab before it has even finished ...

It's being described as the best weight-loss jab yet -with results that outstrip Wegovy or Mounjaro. But anyone hoping to try ...

Affordability and access drive "gray," says Sabina Hemmi, founder of GLP Winner, a consumer watchdog. Some microdose the ...

Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor ...

The year started with a different celebrity gossip. Not a movie, or a scandal. It was the speculative fervour that dramatic ...